HIGHLIGHTS
- who: Pierre-Edouard Debureaux from the Nantes Angers (CRCINA), France University of Kansas Medical Center have published the article: Prognosis of hyperviscosity syndrome in newly diagnosed multiple myeloma in modern-era therapy: A real-life study, in the Journal: (JOURNAL)
- what: The study demonstrates that HVS for NDMM patients is a rare but life-threatening complication associated with early death in older patients. The authors report here the most extensive study of NDMM patients with HVS in the modern era therapy.
- future: HVS seems associated with dismal survival in multiple myeloma but additional . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.